Skip to content

H.R. 10628 · 119th Congress (2025–2027)

Biosimilars Access and Affordability Act

To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 10628’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Nicholas A. Langworthy (R-NY-23)
Cosponsors
11 cosponsors

8 original · 3 later

3 R · 8 D

  1. Rep. Jake Auchincloss (D-MA-4)· Original · Sep 28, 2026
  2. Rep. John Joyce (R-PA-13)· Original · Sep 28, 2026
  3. Rep. Nathaniel Moran (R-TX-1)· Original · Sep 28, 2026
  4. Rep. Kevin Mullin (D-CA-15)· Original · Sep 28, 2026
  5. Rep. Scott H. Peters (D-CA-50)· Original · Sep 28, 2026
  6. Rep. Jimmy Panetta (D-CA-19)· Original · Sep 28, 2026
  7. Rep. Linda T. Sánchez (D-CA-38)· Original · Sep 28, 2026
  8. Rep. Rudy Yakym III (R-IN-2)· Original · Sep 28, 2026
  9. Rep. Donald G. Davis (D-NC-1)· Later · Oct 22, 2026
  10. Rep. Vicente Gonzalez (D-TX-34)· Later · Nov 9, 2026
  11. Rep. Robin L. Kelly (D-IL-2)· Later · Nov 9, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Sep 28, 2026
  2. HouseWays and MeansReferred Sep 28, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Biosimilars Access and Affordability Act

    Display title, Short title · Introduced in House

  2. To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

    Official title · Introduced in House